Mr Andrew Hayes MA, MBBS, FRCS, PhD

Consultant General Surgeon and Surgical Oncologist – Royal Marsden NHS Foundation Trust, Chelsea, UK

Mr Andrew Hayes is a Consultant General Surgeon and Surgical Oncologist on the Sarcoma Unit and the Skin Unit at the Royal Marsden Trust. He qualified at Oxford University and St Bartholomew’s Hospital, London, and undertook his surgical training in London, and a PhD in Washington DC. Andrew has a specialist practice in soft-tissue sarcoma and advanced melanoma, and operates on over 150 cases of sarcoma and another 150 of cases of advanced malignant melanoma a year. He leads the isolated limb perfusion programme which provides a national service for regional chemotherapy for patients with advanced limb malignancy.

Andrew is the president of the British Sarcoma Group – the professional organisation that oversees the treatment of soft tissue sarcoma in the United Kingdom and is co-chair of the London and South East England Sarcoma  Advisory Group.  Within the Royal Marsden, he is Clinical Director of the Rare Cancers Clinical Business Unit and Head of The Royal Marsden’s Skin Unit.  

In 2002, Andrew was awarded a Hunterian Professorship for his research into angiogenesis as a therapeutic approach for cancer.  He is a Reader in Sarcoma and Melanoma Surgery at the Institute of Cancer Research and  is Team Leader of the Sarcoma and Melanoma Surgery Research Group at the ICR. He has a laboratory research program investigating new therapies for extremity malignancies using isolated limb perfusion and is chief investigator on clinical trials of new therapeutic agents for the treatment of  advanced limb malignancies. Andrew has published widely in all aspects of the treatment of sarcoma and melanoma.